Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $44.22 USD
Change Today +0.76 / 1.75%
Volume 922.7K
As of 8:10 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

bio-reference labs inc (BRLI) Snapshot

Open
$43.50
Previous Close
$43.46
Day High
$44.53
Day Low
$43.35
52 Week High
06/4/15 - $46.74
52 Week Low
12/10/14 - $26.32
Market Cap
1.2B
Average Volume 10 Days
611.6K
EPS TTM
$1.86
Shares Outstanding
27.8M
EX-Date
--
P/E TM
23.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for BIO-REFERENCE LABS INC (BRLI)

bio-reference labs inc (BRLI) Related Bloomberg News

View More Bloomberg News

bio-reference labs inc (BRLI) Related Businessweek News

No Related Businessweek News Found

bio-reference labs inc (BRLI) Details

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in the United States. The company focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. It offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. It serves physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

3,406 Employees
Last Reported Date: 01/13/15
Founded in 1981

bio-reference labs inc (BRLI) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $1.2M
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $457.3K
Compensation as of Fiscal Year 2014.

bio-reference labs inc (BRLI) Key Developments

Bio-Reference Laboratories Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended April 30, 2015

Bio-Reference Laboratories Inc. announced unaudited earnings results for the second quarter and six months ended April 30, 2015. For the quarter, the company reported net revenue of $223,986,000 against $201,366,000 a year ago. Operating income was $18,926,000 compared to $18,879,000 a year ago. Income before taxes was $18,281,000 compared to $18,238,000 a year ago. Net income was $10,461,000 compared to $10,273,000 a year ago. Income per diluted share was $0.38 compared with the prior-year period's $0.38 per diluted share. For the six months, the company reported net revenue was $432,820,000 against $382,635,000 a year ago. Operating income was $30,854,000 compared to $24,760,000 a year ago. Income before taxes was $29,785,000 compared to $23,494,000 a year ago. Net income was $17,094,000 compared to $13,227,000 a year ago. Income per diluted share was $0.61 compared with the prior-year period's $0.41 per diluted share. Cash flow from operations for the first six months of full year 2015 was a positive $10,557, compared to a negative $188 in the full year 2014 same period.

Bio-Reference Laboratories Inc., Opko Health, Inc. - M&A Call

To discuss about OPKO to acquire Bio-Reference Laboratories and to discuss Bio-Reference Laboratories’ second quarter financial results

Results

results

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRLI:US $44.22 USD +0.76

BRLI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Foundation Medicine Inc $34.13 USD +1.03
Genomic Health Inc $27.90 USD +0.37
Myriad Genetics Inc $34.85 USD +0.88
NeoGenomics Inc $5.40 USD -0.09
Sequenom Inc $2.93 USD -0.05
View Industry Companies
 

Industry Analysis

BRLI

Industry Average

Valuation BRLI Industry Range
Price/Earnings 23.9x
Price/Sales 1.4x
Price/Book 3.6x
Price/Cash Flow 15.7x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit www.bioreference.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.